相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H. J. Close et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline
Ivan Ting Hin Fung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
Xiangqi Meng et al.
NATURE COMMUNICATIONS (2020)
Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
Gustavo Rodrigues Rossi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Innate lymphoid cell sensing of tissue vitality
Alexander David Barrow et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
Harald Krenzlin et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI
Bridget A. Kennis et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Testosterone Promotes Glioblastoma Cell Proliferation, Migration, and Invasion Through Androgen Receptor Activation
Dulce Carolina Rodriguez-Lozano et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas
Michael Bockmayr et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The Natural Cytotoxicity Receptors in Health and Disease
Alexander David Barrow et al.
FRONTIERS IN IMMUNOLOGY (2019)
Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
Eda K. Holl et al.
FRONTIERS IN IMMUNOLOGY (2019)
Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma
Chen Zhu et al.
ONCOIMMUNOLOGY (2019)
Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival
Andrea Gras Navarro et al.
CANCERS (2019)
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
Allison B. Powell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
A gene expression-based study on immune cell subtypes and glioma prognosis
Qiu-Yue Zhong et al.
BMC CANCER (2019)
Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
Jiacheng Lu et al.
CANCER CELL INTERNATIONAL (2019)
Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases
Gildas Lepennetier et al.
JOURNAL OF NEUROINFLAMMATION (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Anna Galstyan et al.
NATURE COMMUNICATIONS (2019)
The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation
Silvina Romero-Suarez et al.
FRONTIERS IN IMMUNOLOGY (2019)
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger et al.
FRONTIERS IN IMMUNOLOGY (2019)
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas
Feifei Ren et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
Jesus I. Luna et al.
CANCERS (2019)
Exploiting NK Cell Surveillance Pathways for Cancer Therapy
Alexander David Barrow et al.
CANCERS (2019)
Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients
Geoffrey C. Owens et al.
FRONTIERS IN IMMUNOLOGY (2019)
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
Alexander D. Barrow et al.
CELL (2018)
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
Nathan J. Robison et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking
David Taggart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility
Abigail E. Russi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2018)
Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions
Heleen Neeltje Haspels et al.
FRONTIERS IN IMMUNOLOGY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti et al.
SCIENCE (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
Tobias Weiss et al.
CLINICAL CANCER RESEARCH (2018)
Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury
Sachin P. Gadani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study
Renata Ursu et al.
EUROPEAN JOURNAL OF CANCER (2017)
High-dimensional, single-cell characterization of the brain's immune compartment
Ben Korin et al.
NATURE NEUROSCIENCE (2017)
Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007
Rebecca Leece et al.
NEURO-ONCOLOGY (2017)
IL-33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway
Jian-Fei Zhang et al.
ONCOLOGY REPORTS (2017)
Tailoring Natural Killer cell immunotherapy to the tumour microenvironment
Alexander David Barrow et al.
SEMINARS IN IMMUNOLOGY (2017)
High expression of B7-H6 in human glioma tissues promotes tumor progression
Tianwei Jiang et al.
ONCOTARGET (2017)
Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
Anna Karolina Kozlowska et al.
JOURNAL OF CANCER (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
ILC1 Confer Early Host Protection at Initial Sites of Viral Infection
Orr-El Weizman et al.
CELL (2017)
T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation
Brandon Kwong et al.
NATURE IMMUNOLOGY (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
Eric S. Yvon et al.
CYTOTHERAPY (2017)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Tumor infiltrating immune cells in gliomas and meningiomas
Patricia Domingues et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells
Anna K. Kozlowska et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients
Mev Dominguez-Valentin et al.
CANCER RESEARCH (2016)
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy
Ji Young Yoo et al.
CLINICAL CANCER RESEARCH (2016)
Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity
Carter M. Suryadevara et al.
CLINICAL CANCER RESEARCH (2016)
Immune phenotypes predict survival in patients with glioblastoma multiforme
Haouraa Mostafa et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model
Mitsuto Hanihara et al.
JOURNAL OF NEUROSURGERY (2016)
Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue-inducer cell lineage
Isabel E. Ishizuka et al.
NATURE IMMUNOLOGY (2016)
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Christoph S. N. Klose et al.
NATURE IMMUNOLOGY (2016)
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation
Qiang Liu et al.
NATURE NEUROSCIENCE (2016)
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
Xiaoran Zhang et al.
NEURO-ONCOLOGY (2016)
Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells
Gregory J. Baker et al.
ONCOIMMUNOLOGY (2016)
Immune Evasion Strategies of Glioblastoma
Seyed-Mostafa Razavi et al.
FRONTIERS IN SURGERY (2016)
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Se Jeong Lee et al.
BMC CANCER (2015)
TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response
Jianfeng Han et al.
CANCER RESEARCH (2015)
Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE
Julianne K. Hatfield et al.
CELLULAR IMMUNOLOGY (2015)
A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice
Lorne F. Kastrukoff et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
Han-Ching Tseng et al.
JOURNAL OF CANCER (2015)
Transforming growth factor-beta and its implication in the malignancy of gliomas
Laurent-Olivier Roy et al.
TARGETED ONCOLOGY (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
Gregory J. Baker et al.
CANCER RESEARCH (2014)
NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
Andrea Gras Navarro et al.
JOURNAL OF IMMUNOLOGY (2014)
Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection
Ulrich Jarry et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10
Yao Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
Justyna Kmiecik et al.
ONCOIMMUNOLOGY (2014)
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers
Hui Ding et al.
BIOMATERIALS (2013)
Targeting TGF-β signaling in cancer
Lior H. Katz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?
Walter H. Meisen et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
Aurelie Poli et al.
ONCOTARGET (2013)
In vitro natural killer cell immunotherapy for medulloblastoma
Lucia Fernandez et al.
FRONTIERS IN ONCOLOGY (2013)
Immunophenotypic Identification and Characterization of Tumor Cells and Infiltrating Cell Populations in Meningiomas
Patricia H. Domingues et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
Filiberto Cedeno-Laurent et al.
BLOOD (2012)
Immune genes are associated with human glioblastoma pathology and patient survival
Elodie Vauleon et al.
BMC MEDICAL GENOMICS (2012)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
Christopher A. Alvarez-Breckenridge et al.
NATURE MEDICINE (2012)
The Cancer Stem Cell Subtype Determines Immune Infiltration of Glioblastoma
Christoph P. Beier et al.
STEM CELLS AND DEVELOPMENT (2012)
Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology Laboratory investigation
Isaac Yang et al.
JOURNAL OF NEUROSURGERY (2011)
Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
Darya Alizadeh et al.
CLINICAL CANCER RESEARCH (2010)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
Alexandre Carpentier et al.
NEURO-ONCOLOGY (2010)
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
Alessandra Soriani et al.
BLOOD (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice
Chengwen Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition
William H. D. Hallett et al.
JOURNAL OF IMMUNOLOGY (2008)
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity
Roberta Castriconi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Type I IFN contributes to NK cell homeostasis, activation, and antitumor function
Jeremy B. Swann et al.
JOURNAL OF IMMUNOLOGY (2007)
Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1
Patrick Roth et al.
CANCER RESEARCH (2007)
TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
Guenter Eisele et al.
BRAIN (2006)
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier et al.
NEURO-ONCOLOGY (2006)
Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor
DB Rosen et al.
JOURNAL OF IMMUNOLOGY (2005)
Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor
H Aldemir et al.
JOURNAL OF IMMUNOLOGY (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: Implications for immune escape in vivo
J Wischhusen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction
K Honda et al.
NATURE (2005)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines
S Sivori et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
分享论文
